Please ensure Javascript is enabled for purposes of website accessibility

NJBIZ Power 100 A-F (access required)

Mark Alles The biggest pending merger in New Jersey – in fact, the biggest in the world – is Bristol-Myers Squibb’s $74 billion bid for Summit-based Celgene Corp., which is led by Alles. The deal faces opposition from Bristol shareholders, but is still scheduled to close in the third quarter, putting Alles at the center of ...

NJBIZ Business Events

ICON Honors Awards Program 2021

Tuesday, June 22, 2021
ICON Honors Awards Program 2021

NJBIZ Healthcare Heroes 2021

Tuesday, August 24, 2021
NJBIZ Healthcare Heroes 2021

NJBIZ Best Places to Work 2021

Thursday, September 09, 2021
NJBIZ Best Places to Work 2021